Mefenamic acid (Ponstan - Parke Davis) is a new anthranilic acid derivative which is claimed to produce greater relief of pain than aspirin or codeine. It was discovered in the United States, but is not yet marketed there, presumably because it is still awaiting approval by the U. S. Food and Drug Administration. Here it was first marketed last November, shortly before the Dunlop Committee began work.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.